The effect of Dashang Guggul in Medoroga(increased lipid levels).

An open random clinical control trial to assess the effect of Dashang Guggul in medoroga in comparison with Atorvastatin.

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043754

Enrollment

122

Registered

2022-07-06

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients having lakshan of medoroga. 2) Patients having BMI (25.0-39.9) 3) Patients having LDL (100mg/dl â?? 200 mg/dl), Total cholesterol (200mg/dl - 400mg/dl) & Triglycerides (150mg/dl-400mg/dl). 4) Patients of either gender. 5) Patients of age group 18 to 60 years.

Exclusion criteria

Exclusion criteria: 1) Any major systemic diseases like Carcinoma, Tuberculosis etc. 2) K/C/O- Neuropathic ulcer, Peripheral Vascular disease. 3) K/C/O Immunocompressed patients on immunosuppressive drugs. 4) Malignancy disease. 5) Pregnant & Lactating women to be excluded.

Design outcomes

Primary

Measure	Time frame
Effect of Dashang Guggul in MedorogTimepoint: 1. BMI 2. WEIGHT 3. LIPID PROFILE at baseline and 12 weeks	—

Secondary

Measure	Time frame
To assess the effect of Dashang Guggul in comparison with Atorvastatin in Medorog.Timepoint: 1. BMI 2. WEIGHT 3. LIPID PROFILE At Week 6 And Week 12	—

Countries

India

Contacts

Public ContactDr Rinkal Dnyaneshwar Mane

YMT Ayurvedic Medical College and Hospital,Kharghar,Navi mumbai

drpandeymahesh@gmail.com9820006082

Outcome results